Lakeland Industries (LAKE) Expected to Release Quarterly Earnings on Wednesday

by · The Cerbat Gem

Lakeland Industries (NASDAQ:LAKEGet Free Report) is expected to be issuing its Q2 2027 results after the market closes on Wednesday, September 9th. Analysts expect Lakeland Industries to post earnings of ($0.0475) per share and revenue of $51.4820 million for the quarter. Individuals can check the company’s upcoming Q2 2027 earning report page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 4:30 PM ET.

Lakeland Industries (NASDAQ:LAKEGet Free Report) last released its quarterly earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.18. Lakeland Industries had a negative net margin of 10.87% and a negative return on equity of 6.64%. The company had revenue of $47.42 million during the quarter, compared to the consensus estimate of $47.36 million. On average, analysts expect Lakeland Industries to post $-0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Lakeland Industries Stock Performance

Shares of LAKE opened at $11.95 on Tuesday. The company has a 50-day simple moving average of $11.58 and a two-hundred day simple moving average of $10.31. The company has a debt-to-equity ratio of 0.20, a current ratio of 3.09 and a quick ratio of 1.34. The firm has a market capitalization of $117.95 million, a PE ratio of -5.61 and a beta of 1.45. Lakeland Industries has a one year low of $7.15 and a one year high of $18.00.

Institutional Investors Weigh In On Lakeland Industries

Several hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets increased its stake in shares of Lakeland Industries by 87.8% during the third quarter. BNP Paribas Financial Markets now owns 1,795 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 839 shares in the last quarter. Bank of America Corp DE boosted its position in shares of Lakeland Industries by 189.9% in the 2nd quarter. Bank of America Corp DE now owns 4,177 shares of the medical instruments supplier’s stock worth $57,000 after purchasing an additional 2,736 shares in the last quarter. JPMorgan Chase & Co. bought a new stake in shares of Lakeland Industries in the 2nd quarter worth approximately $59,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Lakeland Industries in the 2nd quarter worth approximately $68,000. Finally, Wells Fargo & Company MN grew its stake in shares of Lakeland Industries by 35.5% in the 4th quarter. Wells Fargo & Company MN now owns 9,514 shares of the medical instruments supplier’s stock worth $84,000 after buying an additional 2,492 shares during the last quarter. Institutional investors own 71.69% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on LAKE shares. DA Davidson increased their target price on Lakeland Industries from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Thursday, June 11th. Weiss Ratings upgraded Lakeland Industries from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 29th. Finally, Wall Street Zen raised Lakeland Industries from a “sell” rating to a “hold” rating in a research note on Sunday, July 12th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $16.00.

Get Our Latest Analysis on Lakeland Industries

Lakeland Industries Company Profile

(Get Free Report)

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.

Recommended Stories